Compugen Ltd. (CGEN)
2.80
+0.19
(+7.28%)
USD |
NASDAQ |
May 22, 16:00
2.80
0.00 (0.00%)
After-Hours: 20:00
Compugen EPS Diluted (Quarterly) : -0.0811 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.612 |
| Pluri, Inc. | -0.5518 |
| BioLineRx Ltd. | -0.32 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.0716 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.669M |
| Revenue (Quarterly) | 2.176M |
| Total Expenses (Quarterly) | 9.845M |
| Enterprise Value | 132.82M |
| Gross Profit Margin (Quarterly) | 16.18% |
| Profit Margin (Quarterly) | -352.4% |
| Earnings Yield | 13.07% |
| Operating Earnings Yield | 11.66% |
| Normalized Earnings Yield | 13.07 |